filmov
tv
Webinar: Focused Ultrasound and Alzheimer's Disease
Показать описание
In recognition of World Alzheimer’s Day, the Focused Ultrasound Foundation partnered with USAgainstAlzheimer’s and the Global Alzheimer’s Platform Foundation to host a special webinar on focused ultrasound for Alzheimer’s disease on September 20, 2022.
Alzheimer's disease (AD) is a looming health crisis and, according to the US Centers for Disease Control, there are approximately 6 million people in the US aged 65 or older living with AD. This number is projected to nearly triple by 2060. It is estimated that the cost associated with treating the disease in the US could reach $500 billion annually by 2040.
CHAPTERS
00:00 Introduction
03:12 Presentation: George Vradenburg
09:21 Presentation: Nir Lipsman, MD, PhD
18:26 Presentation: Arjun (JJ) Desai, MD
32:03 Presentation: Sandra Black, OC, O.Ont., MD, FRSC
01:02:14 Q&A
01:13:08 Conclusion
PANELISTS
Sandra Black, OC, O.Ont., MD, FRSC
A renowned neurologist, senior scientist, and director of the Dr. Sandra Black Centre for Brain Resilience & Recovery at Sunnybrook Research Institute in Toronto, Dr. Black discusses the current status of AD treatments and the potential of focused ultrasound to overcome current barriers.
Nir Lipsman, MD, PhD
A neurosurgeon at Sunnybrook Health Sciences Centre in Toronto, director of the Harquail Centre of Neuromodulation at Sunnybrook and a leading researcher in focused ultrasound and Alzheimer's disease, Dr. Lipsman provides an overview of progress with FUS and AD, highlighting current clinical trials.
Arjun (JJ) Desai, MD
Insightec’s Chief Strategic Innovation Officer Arjun (JJ) Desai, MD, highlights the innovative Florida Brain State Initiative, a collaboration between three prominent medical schools in Florida, state government, and industry (Insightec) to fund a multicenter-focused ultrasound clinical trial for and AD.
John R. Dwyer, Jr.
President of the Global Alzheimer’s Platform Foundation
George Vradenburg
Chairman and co-founder of USAgainstAlzheimer’s
HOST
Suzanne LeBlang, MD
FUSF RESOURCES
Website:
Subscribe to the Newsletter:
Read the latest issue:
Alzheimer's disease (AD) is a looming health crisis and, according to the US Centers for Disease Control, there are approximately 6 million people in the US aged 65 or older living with AD. This number is projected to nearly triple by 2060. It is estimated that the cost associated with treating the disease in the US could reach $500 billion annually by 2040.
CHAPTERS
00:00 Introduction
03:12 Presentation: George Vradenburg
09:21 Presentation: Nir Lipsman, MD, PhD
18:26 Presentation: Arjun (JJ) Desai, MD
32:03 Presentation: Sandra Black, OC, O.Ont., MD, FRSC
01:02:14 Q&A
01:13:08 Conclusion
PANELISTS
Sandra Black, OC, O.Ont., MD, FRSC
A renowned neurologist, senior scientist, and director of the Dr. Sandra Black Centre for Brain Resilience & Recovery at Sunnybrook Research Institute in Toronto, Dr. Black discusses the current status of AD treatments and the potential of focused ultrasound to overcome current barriers.
Nir Lipsman, MD, PhD
A neurosurgeon at Sunnybrook Health Sciences Centre in Toronto, director of the Harquail Centre of Neuromodulation at Sunnybrook and a leading researcher in focused ultrasound and Alzheimer's disease, Dr. Lipsman provides an overview of progress with FUS and AD, highlighting current clinical trials.
Arjun (JJ) Desai, MD
Insightec’s Chief Strategic Innovation Officer Arjun (JJ) Desai, MD, highlights the innovative Florida Brain State Initiative, a collaboration between three prominent medical schools in Florida, state government, and industry (Insightec) to fund a multicenter-focused ultrasound clinical trial for and AD.
John R. Dwyer, Jr.
President of the Global Alzheimer’s Platform Foundation
George Vradenburg
Chairman and co-founder of USAgainstAlzheimer’s
HOST
Suzanne LeBlang, MD
FUSF RESOURCES
Website:
Subscribe to the Newsletter:
Read the latest issue:
Комментарии